Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
Shenzhen Stock ExchangeTotal Valuation
Shenzhen Mindray Bio-Medical Electronics Co., Ltd. carries a market capitalization of 167.52B, placing it among publicly traded companies globally. Its enterprise value stands at 186.52B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 167.52B |
| Enterprise Value | 186.52B |
Share Statistics
Shenzhen Mindray Bio-Medical Electronics Co., Ltd. currently has 1.21B shares outstanding.
| Shares Outstanding | 1.21B |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Valuation Ratios
Shenzhen Mindray Bio-Medical Electronics Co., Ltd. trades at a trailing price-to-earnings ratio of 37.40. The price-to-sales ratio is 8.21, and the price-to-book ratio stands at 5.92.
| PE Ratio | 37.40 |
| PS Ratio | 8.21 |
| PB Ratio | 5.92 |
| P/TBV Ratio | 7.35 |
| P/FCF Ratio | 122.34 |
| P/OCF Ratio | N/A |
Enterprise Valuation
On an enterprise value basis, Shenzhen Mindray Bio-Medical Electronics Co., Ltd. trades at an EV/EBITDA multiple of 28.19 and an EV/FCF ratio of 112.79. The EV/Sales ratio of 7.67 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 28.19 provides insight into valuation relative to core operating earnings.
| EV / Sales | 7.67 |
| EV / EBITDA | 28.19 |
| EV / EBIT | 28.19 |
| EV / FCF | 112.79 |
Financial Position
Shenzhen Mindray Bio-Medical Electronics Co., Ltd. maintains a current ratio of 2.39, meaning it holds 2.4x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 0.76, indicating moderate leverage, while an interest coverage ratio of 263.55 demonstrates strong ability to service its debt obligations.
| Current Ratio | 2.39 |
| Quick Ratio | 1.54 |
| Debt / Equity | 0.76 |
| Debt / EBITDA | 0.05 |
| Interest Coverage | 263.55 |
Financial Efficiency
Shenzhen Mindray Bio-Medical Electronics Co., Ltd. posts a return on equity of 16.38 and a return on invested capital of 13.36.
| Return on Equity (ROE) | 16.38 |
| Return on Assets (ROA) | 9.04 |
| Return on Invested Capital (ROIC) | 13.36 |
| Return on Capital Employed (ROCE) | 13.48 |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | 1.90 |
Taxes
Over the trailing twelve months, Shenzhen Mindray Bio-Medical Electronics Co., Ltd. has paid 572.13M in income taxes, reflecting an effective tax rate of 9.26.
| Income Tax | 572.13M |
| Effective Tax Rate | 9.26 |
Stock Price Statistics
Shenzhen Mindray Bio-Medical Electronics Co., Ltd.'s stock has declined approximately -36.1536% over the past 52 weeks. The 50-day moving average sits at 151.88, while the 200-day moving average is 184.73.
| Beta (5Y) | N/A |
| 52-Week Price Change | -36.1536% |
| 50-Day Moving Average | 151.88 |
| 200-Day Moving Average | 184.73 |
| Average Volume (20 Days) | N/A |
Income Statement
Over the trailing twelve months, Shenzhen Mindray Bio-Medical Electronics Co., Ltd. generated 24.31B in revenue and converted that into 5.34B in net income, yielding earnings per share of 4.62. EBITDA reached 6.62B, while operating income came in at 6.62B.
| Revenue | 24.31B |
| Gross Profit | 14.41B |
| Operating Income | 6.62B |
| Pretax Income | 6.18B |
| Net Income | 5.34B |
| EBITDA | 6.62B |
| EBIT | 6.62B |
| Earnings Per Share (EPS) | 4.62 |
Balance Sheet
Shenzhen Mindray Bio-Medical Electronics Co., Ltd. holds 18.09B in cash and equivalents against 342.96M in total debt, resulting in a net debt position of -17.79B. Total book value stands at 33.68B, with working capital of 16.31B providing operational flexibility.
| Cash & Cash Equivalents | 18.09B |
| Total Debt | 342.96M |
| Net Debt | -17.79B |
| Equity (Book Value) | 33.68B |
| Book Value Per Share | 27.80 |
| Working Capital | 16.31B |
Cash Flow
After subtracting -1.63B in capital expenditures, free cash flow totaled -1.63B - equivalent to -1.35 per share.
| Operating Cash Flow | N/A |
| Capital Expenditures | -1.63B |
| Free Cash Flow | -1.63B |
| FCF Per Share | -1.35 |
Margins
Shenzhen Mindray Bio-Medical Electronics Co., Ltd. operates with a gross margin of 59.29, reflecting its pricing power and cost economics. The operating margin of 27.22 and net profit margin of 21.95 provide insight into operational efficiency.
| Gross Margin | 59.29 |
| Operating Margin | 27.22 |
| Pretax Margin | 25.41 |
| Profit Margin | 21.95 |
| EBITDA Margin | 27.22 |
Dividends & Yields
The company's payout ratio of 68.55 indicates the proportion of earnings distributed to shareholders.
| Dividend Per Share | 3.32 |
| Dividend Yield | N/A |
| Payout Ratio | 68.55 |
| Shareholder Yield | 2.39 |
| FCF Yield | 0.82 |
Scores
Shenzhen Mindray Bio-Medical Electronics Co., Ltd. posts an Altman Z-Score of 10.76, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 10.76 |